Elsevier

Annals of Vascular Surgery

Volume 15, Issue 6, November 2001, Pages 628-633
Annals of Vascular Surgery

Relationship of the 20S Proteasome and the Proteasome Activator PA28 to Atherosclerosis and Intimal Hyperplasia in the Human Vascular System

https://doi.org/10.1007/s10016-001-0055-2Get rights and content

Down-regulation of the proteasome activator PA28 results in abnormal proteasome activation and has been implicated in the development of intimal hyperplasia (IH) in animal models. Demonstration of proteasome and PA28 expression has not yet been documented in the human vascular system. This study sought to define the distribution of the 20S proteasome and its activator PA28 in human vessels and determine the relationship between the expression of the proteasome and PA28 and the development of atherosclerosis and IH. Vascular biopsies were obtained from 70 patients at the time of surgery, were snap frozen and sectioned in 5-μm sections, and prepared using standard histological techniques. The immunoperoxidase technique was used to identify 20S proteasome and PA28 expression in diseased and normal human arteries and veins as well as in patent bypass grafts with and without IH. Expression was graded by a blinded pathologist (scale: 1–4). Repeat quantification of the immunopositive cells was also performed. Expression of 20S proteasome and PA28 was identified in all vascular tissues examined. The proteins were identified predominately within the cytoplasm of vascular smooth muscle cells and endothelial cells. PA28 was more intensely expressed in quiescent regions of the vessel wall as compared to areas undergoing active proliferation and remodeling. PA28-mediated activation of the proteasome may be necessary to maintain normal cellular homeostasis and prevent excessive cellular proliferation in the human vascular system. Abnormalities of proteasome activation may have a significant role in the development of atherosclerosis and IH.

Cited by (7)

  • Plasma proteome of brain-dead organ donors predicts heart transplant outcome

    2022, Journal of Heart and Lung Transplantation
    Citation Excerpt :

    The circulating 20s proteasome is modulated by proteasome activator (PA28) subunits such as proteasome activator subunit 2. Abnormalities of this modulation contribute to increased intimal hyperplasia and atherosclerosis.31 Of note is that 7 proteins found in univariate analysis on acute rejection with hemodynamic compromise were not clearly related to the top pathways observed in brain-dead donors.

  • Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature

    2013, Journal of Vascular Surgery
    Citation Excerpt :

    Neointimal hyperplasia has also been linked to proteasome activity. Faries et al stained biopsy specimens of atherosclerotic and normal vessels, as well as patent and occluded grafts, for 11S proteasome activator (PA28) expression and observed that areas of vessels with less PA28 staining (lower proteasome activity) had increased levels of atherosclerosis and neointimal hyperplasia.25 Finally, Stone et al observed reduced expression of ubiquitin, E2 enzymes, ubiquitin ligase enzymes, and proteasomal subunits at the anastomoses of vein grafts in the carotid arteries of mongrel dogs.26

View all citing articles on Scopus
View full text